| Literature DB >> 32441445 |
Kai J Rogers1, Olena Shtanko2, Laura L Stunz1, Laura N Mallinger1, Tina Arkee3, Megan E Schmidt3, Dana Bohan3, Bethany Brunton1, Judith M White4, Steve M Varga1,3, Noah S Butler1,3, Gail A Bishop1,3,5,6, Wendy Maury1,3.
Abstract
Many acute viral infections target tissue Mϕs, yet the mechanisms of Mϕ-mediated control of viruses are poorly understood. Here, we report that CD40 expressed by peritoneal Mϕs restricts early infection of a broad range of RNA viruses. Loss of CD40 expression enhanced virus replication as early as 12-24 h of infection and, conversely, stimulation of CD40 signaling with an agonistic Ab blocked infection. With peritoneal cell populations infected with the filovirus, wild-type (WT) Ebola virus (EBOV), or a BSL2 model virus, recombinant vesicular stomatitis virus encoding Ebola virus glycoprotein (rVSV/EBOV GP), we examined the mechanism conferring protection. Here, we demonstrate that restricted virus replication in Mϕs required CD154/CD40 interactions that stimulated IL-12 production through TRAF6-dependent signaling. In turn, IL-12 production resulted in IFN-γ production, which induced proinflammatory polarization of Mϕs, protecting the cells from infection. These CD40-dependent events protected mice against virus challenge. CD40-/- mice were exquisitely sensitive to intraperitoneal challenge with a dose of rVSV/EBOV GP that was sublethal to CD40+/+ mice, exhibiting viremia within 12 h of infection and rapidly succumbing to infection. This study identifies a previously unappreciated role for Mϕ-intrinsic CD40 signaling in controlling acute virus infection. ©2020 Society for Leukocyte Biology.Entities:
Keywords: CD40; CD40 signaling; Ebola virus; IFN-γ; IL-12; Mϕ; RNA virus; TRAF6; filovirus; innate immunity; peritoneum; virus restriction
Mesh:
Substances:
Year: 2020 PMID: 32441445 PMCID: PMC7774454 DOI: 10.1002/JLB.4HI0420-285RR
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962